FR2184007A1 - - Google Patents
Info
- Publication number
- FR2184007A1 FR2184007A1 FR7316720A FR7316720A FR2184007A1 FR 2184007 A1 FR2184007 A1 FR 2184007A1 FR 7316720 A FR7316720 A FR 7316720A FR 7316720 A FR7316720 A FR 7316720A FR 2184007 A1 FR2184007 A1 FR 2184007A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/252,030 US4304907A (en) | 1972-05-10 | 1972-05-10 | Bicyclo lactone intermediates for prostaglandin analogs |
US05/426,058 US4303796A (en) | 1972-05-10 | 1973-12-19 | 16-Phenoxy prostaglandin F2α analogs |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2184007A1 true FR2184007A1 (fr) | 1973-12-21 |
FR2184007B1 FR2184007B1 (fr) | 1979-01-12 |
Family
ID=26941978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7316720A Expired FR2184007B1 (fr) | 1972-05-10 | 1973-05-09 |
Country Status (8)
Country | Link |
---|---|
US (8) | US4304907A (fr) |
AU (1) | AU470415B2 (fr) |
BE (1) | BE799372A (fr) |
CH (2) | CH585711A5 (fr) |
DE (1) | DE2322673A1 (fr) |
FR (1) | FR2184007B1 (fr) |
GB (3) | GB1409843A (fr) |
NL (1) | NL7306462A (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2372820A1 (fr) * | 1976-12-02 | 1978-06-30 | Schering Ag | Procede de preparation de derives d'alcenyl-6 oxa-2 bicyclo (3-3-0) octanones-3, intermediaires pour la preparation de prostaglandines |
EP0349658A1 (fr) * | 1986-12-12 | 1990-01-10 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | Prostanoides et leur application pour augmenter le taux de naissance dans des animaux femelles |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3864387A (en) * | 1973-05-21 | 1975-02-04 | Upjohn Co | 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs |
GB1502610A (en) * | 1974-12-12 | 1978-03-01 | Ici Ltd | Process for the preparation of prostaglandin intermediate |
GB1538871A (en) * | 1975-01-24 | 1979-01-24 | Lepetit Spa | Prostaglandins |
US4032561A (en) * | 1975-05-27 | 1977-06-28 | The Upjohn Company | 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds |
US4149006A (en) * | 1977-01-24 | 1979-04-10 | G. D. Searle & Co. | Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain |
EP0096097B1 (fr) * | 1982-06-15 | 1985-12-27 | International Business Machines Corporation | Méthode et dispositif pour contrôler l'accès à un réseau de communication |
US4600785A (en) * | 1983-12-22 | 1986-07-15 | Syntex (U.S.A.) Inc. | Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives |
US4804787A (en) * | 1983-12-22 | 1989-02-14 | Syntex (U.S.A.) Inc. | Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives |
US4912235A (en) * | 1983-12-22 | 1990-03-27 | Syntex (U.S.A.) Inc. | Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers |
US4929740A (en) * | 1984-10-09 | 1990-05-29 | Syntex (U.S.A.) Inc. | Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives |
US4778904A (en) * | 1985-09-13 | 1988-10-18 | Syntex (U.S.A.) Inc. | Intermediates for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives |
US4755531A (en) * | 1986-08-11 | 1988-07-05 | Syntex (U.S.A.) Inc. | Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US6187813B1 (en) | 1990-04-10 | 2001-02-13 | Pharmacia & Upjohn Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
EP0569046B1 (fr) * | 1988-09-06 | 2002-11-13 | Pharmacia Aktiebolag | Dérivés de prostaglandine pour traitement du glaucome ou hypertension oculaire |
US5321128A (en) * | 1988-09-06 | 1994-06-14 | Kabi Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
JP3097145B2 (ja) * | 1991-02-27 | 2000-10-10 | 日産化学工業株式会社 | コーリーラクトンジオールの光学分割方法 |
EP0638605B1 (fr) * | 1993-08-10 | 1998-12-09 | Shin-Etsu Chemical Co., Ltd. | Procédé de préparation d'une résine de polyester modifié par un siloxane et composition durcissable à base de cette résine |
US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US9241918B2 (en) | 2005-03-16 | 2016-01-26 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
WO2010108012A1 (fr) * | 2009-03-18 | 2010-09-23 | Duke University | Compositions et procédés pour améliorer la perméabilité nasale et traiter la vessie neurogène employant des prostaglandines |
US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
SG183498A1 (en) * | 2010-02-25 | 2012-09-27 | Abt Holding Co | Modulation of angiogenesis |
US20110206647A1 (en) * | 2010-02-25 | 2011-08-25 | Abt Holding Company | Modulation of Angiogenesis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2137712A1 (en) * | 1971-05-11 | 1972-12-29 | Ici Ltd | Novel prostanoic acid or its salt used as pharmaceutical or veterinary composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3505386A (en) * | 1965-12-29 | 1970-04-07 | Upjohn Co | Compounds related to prostaglandins |
US3711528A (en) * | 1970-04-06 | 1973-01-16 | Upjohn Co | Racemic dihydro-pge{11 {11 and related compounds |
US3711515A (en) * | 1970-11-27 | 1973-01-16 | Upjohn Co | Tricyclic lactone alkene or alkenyne |
US4024179A (en) * | 1972-11-08 | 1977-05-17 | Pfizer Inc. | Substituted ω-pentanorprostaglandins |
-
1972
- 1972-05-10 US US05/252,030 patent/US4304907A/en not_active Expired - Lifetime
-
1973
- 1973-04-30 AU AU55006/73A patent/AU470415B2/en not_active Expired
- 1973-05-02 GB GB379175A patent/GB1409843A/en not_active Expired
- 1973-05-02 GB GB2091873A patent/GB1409841A/en not_active Expired
- 1973-05-02 GB GB379075A patent/GB1409842A/en not_active Expired
- 1973-05-05 DE DE2322673A patent/DE2322673A1/de not_active Withdrawn
- 1973-05-09 FR FR7316720A patent/FR2184007B1/fr not_active Expired
- 1973-05-09 NL NL7306462A patent/NL7306462A/xx not_active Application Discontinuation
- 1973-05-10 BE BE130979A patent/BE799372A/fr not_active IP Right Cessation
- 1973-05-10 CH CH668973A patent/CH585711A5/xx not_active IP Right Cessation
- 1973-05-10 CH CH584176A patent/CH585712A5/xx not_active IP Right Cessation
- 1973-12-19 US US05/426,058 patent/US4303796A/en not_active Expired - Lifetime
-
1977
- 1977-02-07 US US05/766,010 patent/US4116988A/en not_active Expired - Lifetime
- 1977-02-07 US US05/765,997 patent/US4087616A/en not_active Expired - Lifetime
- 1977-02-07 US US05/766,011 patent/US4116989A/en not_active Expired - Lifetime
- 1977-02-07 US US05/765,919 patent/US4096335A/en not_active Expired - Lifetime
- 1977-02-10 US US05/767,443 patent/US4096178A/en not_active Expired - Lifetime
- 1977-02-10 US US05/767,444 patent/US4096179A/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2137712A1 (en) * | 1971-05-11 | 1972-12-29 | Ici Ltd | Novel prostanoic acid or its salt used as pharmaceutical or veterinary composition |
Non-Patent Citations (2)
Title |
---|
ANNALS OF THE NEW-YORK ACADEMY OF SCIENCES VOL. 180 1971 PAGES 24-37.) * |
J.A.C.S. 93 1971 PAGES 7319-20 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2372820A1 (fr) * | 1976-12-02 | 1978-06-30 | Schering Ag | Procede de preparation de derives d'alcenyl-6 oxa-2 bicyclo (3-3-0) octanones-3, intermediaires pour la preparation de prostaglandines |
EP0349658A1 (fr) * | 1986-12-12 | 1990-01-10 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | Prostanoides et leur application pour augmenter le taux de naissance dans des animaux femelles |
Also Published As
Publication number | Publication date |
---|---|
GB1409841A (en) | 1975-10-15 |
US4087616A (en) | 1978-05-02 |
AU5500673A (en) | 1974-10-31 |
US4304907A (en) | 1981-12-08 |
AU470415B2 (en) | 1976-03-18 |
US4303796A (en) | 1981-12-01 |
FR2184007B1 (fr) | 1979-01-12 |
US4116989A (en) | 1978-09-26 |
CH585711A5 (fr) | 1977-03-15 |
US4096178A (en) | 1978-06-20 |
CH585712A5 (fr) | 1977-03-15 |
BE799372A (fr) | 1973-11-12 |
GB1409842A (en) | 1975-10-15 |
US4116988A (en) | 1978-09-26 |
GB1409843A (en) | 1975-10-15 |
NL7306462A (fr) | 1973-11-13 |
DE2322673A1 (de) | 1973-11-22 |
US4096335A (en) | 1978-06-20 |
US4096179A (en) | 1978-06-20 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |